[1] Thayabaranathan T, Kim J, Cadilhac DA, et al. Global stroke statistics 2022. Int J Stroke, 2022; 17, 946−56. doi:  10.1177/17474930221123175
[2] Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics—2023 update: a report from the american heart association. Circulation, 2023; 147, e93−e621.
[3] Tan SML, Ong SH, Yeo TT, et al. Ischemic and hemorrhagic strokes in young adults: comparison of functional outcomes and return to work after stroke. Clin Neurol Neurosurg, 2023; 233, 107964. doi:  10.1016/j.clineuro.2023.107964
[4] Mohr JP, Albers GW, Amarenco P, et al. American heart association prevention conference. IV. Prevention and rehabilitation of stroke. Etiology of stroke. Stroke, 1997; 28, 1501−6. doi:  10.1161/01.STR.28.7.1501
[5] Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2014; 45, 3754−832. doi:  10.1161/STR.0000000000000046
[6] Qi WW, Ma J, Guan TJ, et al. Risk factors for incident stroke and its subtypes in China: a prospective study. J Am Heart Assoc, 2020; 9, e016352. doi:  10.1161/JAHA.120.016352
[7] Migdady I, Russman A, Buletko AB. Atrial fibrillation and ischemic stroke: a clinical review. Semin Neurol, 2021; 41, 348−64. doi:  10.1055/s-0041-1726332
[8] Lee SH. Symptoms and signs of hemorrhagic stroke. In: Lee SH. Stroke Revisited: Hemorrhagic Stroke. Springer. 2018, 103-8.
[9] Campbell BCV, De Silva DA, Macleod MR, et al. Ischaemic stroke. Nat Rev Dis Primers, 2019; 5, 70. doi:  10.1038/s41572-019-0118-8
[10] Zhang K, Loong SSE, Yuen LZH, et al. Genetics in ischemic stroke: current perspectives and future directions. J Cardiovasc Dev Dis, 2023; 10, 495.
[11] Wazir M, Olanrewaju OA, Yahya M, et al. Lipid disorders and cardiovascular risk: a comprehensive analysis of current perspectives. Cureus, 2023; 15, e51395.
[12] Alloubani A, Nimer R, Samara R. Relationship between hyperlipidemia, cardiovascular disease and stroke: a systematic review. Curr Cardiol Rev, 2021; 17, e051121189015.
[13] Lin WH, Luo SY, Li W, et al. Association between the non-HDL-cholesterol to HDL- cholesterol ratio and abdominal aortic aneurysm from a Chinese screening program. Lipids Health Dis, 2023; 22, 187. doi:  10.1186/s12944-023-01939-4
[14] Wang K, Shan SS, Zheng HB, et al. Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study. Lipids Health Dis, 2018; 17, 196. doi:  10.1186/s12944-018-0848-8
[15] Chiu H, Wu PY, Huang JC, et al. There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5. Sci Rep, 2020; 10, 12749. doi:  10.1038/s41598-020-69794-2
[16] Zuo PY, Chen XL, Liu YW, et al. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease. Nutr Metab Cardiovasc Dis, 2015; 25, 582−7. doi:  10.1016/j.numecd.2015.03.003
[17] Flores-Guerrero JL, Been RA, Shalaurova I, et al. Triglyceride/HDL cholesterol ratio and lipoprotein insulin resistance score: associations with subclinical atherosclerosis and incident cardiovascular disease. Clin Chim Acta, 2024; 553, 117737. doi:  10.1016/j.cca.2023.117737
[18] Hou KG, Song WP, He J, et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and prevalence of periodontitis among US adults: a cross-sectional NHANES study. Sci Rep, 2024; 14, 5558. doi:  10.1038/s41598-024-56276-y
[19] Qing GW, Deng WP, Zhou YX, et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and suicidal ideation in adults: a population-based study in the United States. Lipids Health Dis, 2024; 23, 17. doi:  10.1186/s12944-024-02012-4
[20] Hong HJ, He YJ, Gong ZQ, et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and kidney stones: a cross-sectional study. Lipids Health Dis, 2024; 23, 102. doi:  10.1186/s12944-024-02089-x
[21] Qi XY, Wang SJ, Huang QW, et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and risk of depression among US adults: a cross-sectional NHANES study. J Affect Disord, 2024; 344, 451−7. doi:  10.1016/j.jad.2023.10.064
[22] Micha R, Peñalvo JL, Cudhea F, et al. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA, 2017; 317, 912−24. doi:  10.1001/jama.2017.0947
[23] Yan SY, Sha S, Li SJ, et al. Association between hypertension and stroke in US adults in the National Health and Nutrition Examination Surveys (NHANES) 2007 to 2018. Postgrad Med, 2023; 135, 187−94. doi:  10.1080/00325481.2022.2138470
[24] Jiang SL, Sun MJ, Zhou XY, et al. Association between blood manganese levels and depressive symptoms among US adults: a nationally representative cross-sectional study. J Affect Disord, 2023; 333, 65−71. doi:  10.1016/j.jad.2023.04.032
[25] Civeira F, Arca M, Cenarro A, et al. A mechanism-based operational definition and classification of hypercholesterolemia. J Clin Lipidol, 2022; 16, 813−21. doi:  10.1016/j.jacl.2022.09.006
[26] Chen HL, Wu CW, Cao L, et al. The association between the neutrophil-to-lymphocyte ratio and type 2 diabetes mellitus: a cross-sectional study. BMC Endocr Disord, 2024; 24, 107. doi:  10.1186/s12902-024-01637-x
[27] Team DC. DecisionLinnc. 1.0. https://www.statsape.com/, 2023.
[28] Lu YZ, Cui XL, Zhang L, et al. The functional role of lipoproteins in atherosclerosis: novel directions for diagnosis and targeting therapy. Aging Dis, 2022; 13, 491−520. doi:  10.14336/AD.2021.0929
[29] Rehberger Likozar A, Zavrtanik M, Šebeštjen M Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options. Ann Med, 2020; 52, 162-77.
[30] Behbodikhah J, Ahmed S, Elyasi A, et al. Apolipoprotein B and Cardiovascular disease: biomarker and potential therapeutic target. Metabolites, 2021; 11, 690. doi:  10.3390/metabo11100690
[31] Johannesen CDL, Langsted A, Nordestgaard BG, et al. Excess apolipoprotein b and cardiovascular risk in women and men. J Am Coll Cardiol, 2024; 83, 2262−73.
[32] Parhofer KG. Increasing HDL-cholesterol and prevention of atherosclerosis: a critical perspective. Atheroscler Suppl, 2015; 18, 109−11. doi:  10.1016/j.atherosclerosissup.2015.02.020
[33] Ouimet M, Barrett TJ, Fisher EA. HDL and reverse cholesterol transport: basic mechanisms and their roles in vascular health and disease. Circ Res, 2019; 124, 1505−18. doi:  10.1161/CIRCRESAHA.119.312617
[34] Gong XX, Chen LW, Song B, et al. Associations of lipid profiles with the risk of ischemic and hemorrhagic stroke: a systematic review and meta-analysis of prospective cohort studies. Front Cardiovasc Med, 2022; 9, 893248. doi:  10.3389/fcvm.2022.893248
[35] Liu YT, Jin XL, Fu KL, et al. Non-traditional lipid profiles and the risk of stroke: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis, 2023; 33, 698−714. doi:  10.1016/j.numecd.2023.01.003
[36] Holmes MV, Millwood IY, Kartsonaki C, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol, 2018; 71, 620−32. doi:  10.1016/j.jacc.2017.12.006
[37] Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke, 1992; 23, 1556−62. doi:  10.1161/01.STR.23.11.1556
[38] Oravec S, Krivošíková Z, Krivošík M, et al. Lipoprotein profile in patients who survive a stroke. Neuro Endocrinol Lett, 2011; 32, 496−501.